Skip to content
Catalyst

esomeprazolePapers

Papers about esomeprazole

papers
199
27 years, by papers

Newest first

1 to 50 of 199

Every paper here, unless its row says otherwiseIndexed under esomeprazole in PubMed's chemical list

  • Fourteen-and Ten-Day Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for Helicobacter pylori Eradication-A Noninferiority, Multicenter, Randomized Controlled Trial.

    Journal of gastroenterology and hepatology2026PMID 41371765Also indexed under esomeprazole as a PubMed major topic

  • Efficacy and Safety of Keverprazan-Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial.

    Helicobacter2026PMID 41645038

  • Eradication efficacy of empiric bismuth quadruple therapy containing amoxicillin in the first-line treatment of Helicobacter pylori in Ningxia, China.

    BMC gastroenterology2026PMID 41904371

  • Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.

    Scientific reports2026PMID 42162236Also indexed under esomeprazole as a PubMed major topic

  • REAL-WORLD EFFECTIVENESS OF HIGH-DOSE DUAL THERAPY VS OPTIMIZED CLARITHROMYCIN TRIPLE THERAPY FOR HELICOBACTER PYLORI: A PROSPECTIVE COHORT STUDY WITH TEST-OF-CURE SENSITIVITY ANALYSES.

    Arquivos de gastroenterologia2026PMID 42615755Also gives esomeprazole alongside what it tests; compares against esomeprazole; indexed under esomeprazole as a PubMed major topic

  • Clinical Impact of High-dose Esomeprazole-amoxicillin Dual Therapy as Rescue Treatment for Helicobacter pylori Infection : A Prospective, Multicenter, Randomized Trial.

    Journal of clinical gastroenterology2025PMID 39495800Also indexed under esomeprazole as a PubMed major topic

  • Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour.

    British journal of clinical pharmacology2025PMID 39891382Also indexed under esomeprazole as a PubMed major topic

  • Effect of Gastric pH on the Pharmacokinetics of Atorvastatin and its Metabolites in Healthy Participants.

    European journal of drug metabolism and pharmacokinetics2025PMID 39956861

  • Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which's better?

    World journal of gastroenterology2025PMID 40248055

  • Prospective Randomised Study of a 14 day Clarithromycin Triple Regimen and a 14 Day Bismuth based Quadruple Regimen for Helicobacter Pylori Eradication.

    Journal of gastrointestinal and liver diseases2025PMID 40843502

  • Assessing Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Incidence of Major Adverse Cardiovascular Events: A Retrospective Cohort Study.

    Pharmacoepidemiology and drug safety2025PMID 41085374

  • Predictive Value of Laryngeal Mucosa Pepsin in Therapeutic Response of Laryngopharyngeal Reflux.

    Journal of voice2024PMID 35760633

  • Eradication rate and adherence with high-dose amoxicillin and proton pump inhibitor as first-line treatment for Helicobacter pylori infection: Experience from University Hospital in Chile.

    Helicobacter2024PMID 38332683

  • A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.

    Helicobacter2024PMID 38411303Also indexed under esomeprazole as a PubMed major topic

  • Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial.

    Helicobacter2024PMID 38853394

  • Efficacy and Safety of Postbiotic Contained Inactivated Lactobacillus reuteri ( Limosilactobacillus reuteri ) DSM 17648 as Adjuvant Therapy in the Eradication of Helicobacter pylori in Adults With Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Trial.

    Clinical and translational gastroenterology2024PMID 39023173

  • Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study.

    Journal of gastroenterology and hepatology2024PMID 39188083Also indexed under esomeprazole as a PubMed major topic

  • Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated Esomeprazole.

    Clinical therapeutics2024PMID 39289057Also indexed under esomeprazole as a PubMed major topic; tests esomeprazole

  • Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori.

    BMC gastroenterology2024PMID 39592940Also indexed under esomeprazole as a PubMed major topic

  • A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease.

    Gut and liver2023PMID 35730245Also indexed under esomeprazole as a PubMed major topic

  • High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.

    British journal of clinical pharmacology2023PMID 35947524

  • Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.

    Helicobacter2023PMID 36374159

  • Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia.

    European journal of clinical pharmacology2023PMID 36380227Also indexed under esomeprazole as a PubMed major topic

  • Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.

    Clinics and research in hepatology and gastroenterology2023PMID 36400418

  • Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study.

    Helicobacter2023PMID 36633162

  • Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.

    BMC infectious diseases2023PMID 36670359

  • A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.

    The Journal of antimicrobial chemotherapy2023PMID 36719104

  • Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.

    Chinese medical journal2023PMID 37010246

  • CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.

    Clinical and translational science2023PMID 37551775

  • Comparative Efficacy of Tegoprazan vs Esomeprazole/Sodium Bicarbonate for the Treatment of Helicobacter pylori Infection.

    Clinical and translational gastroenterology2023PMID 37561041

  • Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1).

    Hypertension (Dallas, Tex.2022PMID 35341328

  • Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication.

    European journal of cancer prevention2022PMID 35471812

  • Pharmacokinetics of Esomeprazole Magnesium After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.

    Clinical pharmacology in drug development2022PMID 35822412Also indexed under esomeprazole as a PubMed major topic

  • Auricular Point-Pressing With Bean Plus Esomeprazole Magnesium in Relieving Gastrointestinal Dysfunction.

    Alternative therapies in health and medicine2022PMID 35839117

  • Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.

    Chinese medical journal2022PMID 36193978

  • Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.

    Advances in therapy2021PMID 33575950Also indexed under esomeprazole as a PubMed major topic

  • Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.

    European journal of gastroenterology & hepatology2020PMID 31851093

  • Esomeprazole vs pantoprazole effects on cyclosporine levels in kidney transplantation: A randomized clinical trial.

    Therapeutic apheresis and dialysis2020PMID 31856374

  • A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations.

    British journal of clinical pharmacology2020PMID 32110830

  • Factors Affecting Quality of Life and Satisfaction in Patients with Arthritis after Change to a Fixed-Dose Naproxen/Esomeprazole Combination Drug.

    Clinics in orthopedic surgery2020PMID 32117543

  • A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.

    Helicobacter2020PMID 33040439Also indexed under esomeprazole as a PubMed major topic

  • A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection.

    Indian journal of pharmacology2020PMID 33078727

  • Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.

    Clinical and translational gastroenterology2020PMID 33094958

  • Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study.

    Medicine2019PMID 30732192

  • A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial.

    The Journal of antimicrobial chemotherapy2019PMID 30768161

  • Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial.

    Helicobacter2019PMID 30780194

  • High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.

    Helicobacter2019PMID 31111580

  • Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy.

    Clinical drug investigation2019PMID 31267433

  • The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male.

    Drug design, development and therapy2019PMID 31564831

  • Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial.

    Digestion2018PMID 29310119

The next 50 papers